. . . . . . . "[In addition to selective inhibitors of ERK1/2, AKT, IKB? and NF-??, as therapeutic options, our data, for the first time, indicates carbonic anhydrase I and II as attractive targets for development of diagnostic tools enabling selection of patients for a more specific therapy in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:00+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .